Refining Treatment Approaches for Chronic Lymphocytic Leukemia - Episode 18
CLL: Final Thoughts
William Wierda, MD, PhD, University of Texas MD Anderson Cancer Center, John Allan, MD, Weill Cornell Medicine, Ehab Atallah, MD, Medical College of Wisconsin, Steven Coutre, MD, Stanford University Medical Center, Nicole Lamanna, MD, Herbert Irving Comprehensive Cancer Center, Jennifer Woyach, MD, Ohio State University
An expert panel provides their final thoughts about the future of the chronic lymphocytic leukemia (CLL) treatment landscape.
